Prospective study to obtain magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) data in paediatric patients with malignant brain tumour treated with Nimotuzumab

Trial Profile

Prospective study to obtain magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) data in paediatric patients with malignant brain tumour treated with Nimotuzumab

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Dec 2015

At a glance

  • Drugs Nimotuzumab (Primary)
  • Indications Brain cancer
  • Focus Diagnostic use; Pharmacodynamics
  • Most Recent Events

    • 10 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top